Partnering structure : 

• Strategic equity investment  

• Onward Therapeutics is the majority shareholder of Emercell

 

Emercell works in collaboration with Onward Therapeutics a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough medicines for the treatment of cancer.